BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3050411)

  • 21. A preliminary report on clinical response and plasma levels of clomipramine and desmethylclomipramine in obsessive-compulsive neurosis.
    Stern RS; Cobb JP; Marks IM; Jones RB; Luscombe DK
    Postgrad Med J; 1977; 53 Suppl 4():97-103. PubMed ID: 341110
    [No Abstract]   [Full Text] [Related]  

  • 22. Clomipramine: plasma levels, side effects and outcome in obsessive-compulsive neurosis.
    Stern RS; Marks IM; Wright J; Luscombe DK
    Postgrad Med J; 1980; 56 Suppl 1():134-9. PubMed ID: 7393824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of obsessive-compulsive disorder with clomipramine and desipramine in children and adolescents. A double-blind crossover comparison.
    Leonard HL; Swedo SE; Rapoport JL; Koby EV; Lenane MC; Cheslow DL; Hamburger SD
    Arch Gen Psychiatry; 1989 Dec; 46(12):1088-92. PubMed ID: 2686576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A predictive study of obsessive-compulsive disorder response to clomipramine.
    Alarcon RD; Libb JW; Spitler D
    J Clin Psychopharmacol; 1993 Jun; 13(3):210-3. PubMed ID: 8354737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Obsessive-compulsive disorder.
    Insel TR
    Psychiatr Clin North Am; 1985 Mar; 8(1):105-17. PubMed ID: 3887336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clonidine and clomipramine in obsessive-compulsive disorder.
    Hollander E; Fay M; Liebowitz MR
    Am J Psychiatry; 1988 Mar; 145(3):388-9. PubMed ID: 3278632
    [No Abstract]   [Full Text] [Related]  

  • 27. Lithium and tryptophan augmentation in clomipramine-resistant obsessive-compulsive disorder.
    Rasmussen SA
    Am J Psychiatry; 1984 Oct; 141(10):1283-5. PubMed ID: 6435460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Double-blind comparative study of clomipramine and amitriptyline in obsessive neurosis.
    Ananth J; Pecknold JC; van den Steen N; Engelsmann F
    Prog Neuropsychopharmacol; 1981; 5(3):257-62. PubMed ID: 7022517
    [No Abstract]   [Full Text] [Related]  

  • 29. Predictors of treatment response in obsessive-compulsive disorder: multivariate analyses from a multicenter trial of clomipramine.
    Ackerman DL; Greenland S; Bystritsky A; Morgenstern H; Katz RJ
    J Clin Psychopharmacol; 1994 Aug; 14(4):247-54. PubMed ID: 7962680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Drug treatment of obsessive-compulsive disorders--a comparative study of the effectiveness of clomipramine and fluoxetine].
    Volk S
    Fortschr Neurol Psychiatr; 1995 Jun; 63 Suppl 1():28-32. PubMed ID: 7635392
    [No Abstract]   [Full Text] [Related]  

  • 31. Buspirone in obsessive-compulsive disorder.
    Maruno CA; Hart LL
    Ann Pharmacother; 1992 Oct; 26(10):1248-51. PubMed ID: 1421651
    [No Abstract]   [Full Text] [Related]  

  • 32. Symptoms and physiologic manifestations in obsessive compulsive patients before and after treatment with clomipramine.
    Hoehn-Saric R; McLeod DR; Zimmerli WD; Hipsley PA
    J Clin Psychiatry; 1993 Jul; 54(7):272-6. PubMed ID: 8335655
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Obsessional compulsive neurosis--a method of treatment.
    Perera HV
    Ceylon Med J; 1981 Dec; 26(4):169-72. PubMed ID: 7348612
    [No Abstract]   [Full Text] [Related]  

  • 34. Anorgasmia from clomipramine in obsessive-compulsive disorder. A controlled trial.
    Monteiro WO; Noshirvani HF; Marks IM; Lelliott PT
    Br J Psychiatry; 1987 Jul; 151():107-12. PubMed ID: 3315086
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clomipramine in obsessive-compulsive disorder: a review.
    Ananth J
    Psychosomatics; 1983 Aug; 24(8):723-7. PubMed ID: 6356210
    [No Abstract]   [Full Text] [Related]  

  • 36. Clomipramine and imipramine in obsessive-compulsive disorder.
    Volavka J; Neziroglu F; Yaryura-Tobias JA
    Psychiatry Res; 1985 Jan; 14(1):85-93. PubMed ID: 3887445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clomipramine versus phenelzine in obsessive-compulsive disorder. A controlled clinical trial.
    Vallejo J; Olivares J; Marcos T; Bulbena A; Menchón JM
    Br J Psychiatry; 1992 Nov; 161():665-70. PubMed ID: 1422616
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggravation of schizophrenia by clomipramine in a patient with comorbid obsessive-compulsive disorder.
    Margetić B; Aukst-Margetić B; Jakovljević M
    Psychopharmacol Bull; 2008; 41(2):9-11. PubMed ID: 18668013
    [No Abstract]   [Full Text] [Related]  

  • 39. Antiobsessional and antidepressant effects of clomipramine in the treatment of obsessive-compulsive disorder.
    Insel TR; Alterman I; Murphy DL
    Psychopharmacol Bull; 1982 Oct; 18(4):115-7. PubMed ID: 7156271
    [No Abstract]   [Full Text] [Related]  

  • 40. Clomipramine side effects.
    Cruz R
    J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1168-9. PubMed ID: 1429426
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.